Guardant Health, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2022
For the year, the company expects Revenue of between $447 million and $450 million, an increase of 20%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.83 USD | +7.26% | +22.35% | +25.06% |
07-12 | GoodRx Holdings, Inc. Announces the Election of Ian T. Clark to its Board of Directors | CI |
06-28 | Top Premarket Gainers | MT |
1st Jan change | Capi. | |
---|---|---|
+25.06% | 3.86B | |
-32.86% | 8.68B | |
+15.74% | 2.43B | |
-26.46% | 1.84B | |
-7.09% | 1.73B | |
+40.61% | 1.16B | |
+54.75% | 842M | |
-9.17% | 702M | |
-9.18% | 594M | |
-19.58% | 239M |